Cambrooke Therapeutics announced the launch of Tylactin RESTORE Powder, a new medical hydration beverage for the dietary management of tyrosinemia. Cambrooke Therapeutics announced the launch of ...
AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactinâ„¢ RESTORE ...
Cambrooke Therapeutics announced the launch of Glytactin RESTORE Powder and Glytactin RESTORE Lite Powder, new medical food hydration beverages for the dietary management of phenylketonuria (PKU).